ARYA Sciences Acquisition Corp IV
ARYD · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $87,414 | $86,404 | $80,371 | $78,146 |
| - Cash | $88 | $20 | $14 | $18 |
| + Debt | $3,145 | $2,175 | $1,705 | $1,260 |
| Enterprise Value | $90,472 | $88,559 | $82,062 | $79,388 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$612 | $38 | -$960 | -$79 |
| % Margin | – | – | – | – |
| Net Income | -$246 | -$2,220 | -$455 | $382 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.032 | -0.28 | -0.061 | 0.051 |
| % Growth | 88.7% | -356.8% | -219.3% | – |
| Operating Cash Flow | -$512 | -$44 | -$29 | -$442 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$512 | -$44 | -$29 | -$442 |